We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Chinese health experts have reportedly estimated that "at least 30,000 children developed early maturity" in Shanghai alone, raising concerns about food additives and pesticides allegedly laden with sex hormones
North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province
California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China
